PTGER2
Prostaglandin E2 receptor EP2 subtype
Also known as: EP2, PE2R2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P43116
- Gene
- PTGER2
- Ensembl
- ENSG00000125384
- Chromosome
- 14
- Canonical length
- 358 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a receptor for prostaglandin E2, a metabolite of arachidonic acid which has different biologic activities in a wide range of tissues. Mutations in this gene are associated with aspirin-induced susceptibility to asthma. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
358 residues, UniProt reviewed canonical sequence.
>P43116|PTGER2
1 MGNASNDSQS EDCETRQWLP PGESPAISSV MFSAGVLGNL IALALLARRW RGDVGCSAGR
61 RSSLSLFHVL VTELVFTDLL GTCLISPVVL ASYARNQTLV ALAPESRACT YFAFAMTFFS
121 LATMLMLFAM ALERYLSIGH PYFYQRRVSR SGGLAVLPVI YAVSLLFCSL PLLDYGQYVQ
181 YCPGTWCFIR HGRTAYLQLY ATLLLLLIVS VLACNFSVIL NLIRMHRRSR RSRCGPSLGS
241 GRGGPGARRR GERVSMAEET DHLILLAIMT ITFAVCSLPF TIFAYMNETS SRKEKWDLQA
301 LRFLSINSII DPWVFAILRP PVLRLMRSVL CCRISLRTQD ATQTSCSTQS DASKQADLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTGER2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 36 nTPM
- stomach: 17 nTPM
- cervix: 16 nTPM
- placenta: 14 nTPM
- appendix: 12 nTPM
- ovary: 11 nTPM
Single-cell type
- monocytes: 98 nCPM
- nk-cells: 69 nCPM
- t-cells: 54 nCPM
- kupffer cells: 49 nCPM
- neutrophil progenitors: 49 nCPM
- mucous neck cells: 44 nCPM
Immune cell
- MAIT T-cell: 130 nTPM
- memory CD8 T-cell: 114 nTPM
- gdT-cell: 107 nTPM
- memory CD4 T-cell: 91 nTPM
- NK-cell: 74 nTPM
- naive CD8 T-cell: 68 nTPM
Brain region
- choroid plexus: 6.4 nTPM
- medulla oblongata: 1.7 nTPM
- basal ganglia: 1.5 nTPM
- spinal cord: 1.4 nTPM
- midbrain: 1.3 nTPM
- cerebral cortex: 1.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTGER2.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 57 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- cellular response to prostaglandin E stimulus
- G protein-coupled receptor signaling pathway
- inflammatory response
- positive regulation of cytosolic calcium ion concentration
- regulation of cell population proliferation
- response to lipopolysaccharide
- response to nematode
- response to progesterone
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTGER2 as an antibody target. Whether an autoantibody or antibody against PTGER2 could matter depends on whether native PTGER2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTGER2 is annotated at the cell surface, where native PTGER2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PTGER2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...